Universal Medica Seeks Client Partners in Phase I Oncology Therapeutics Projects

Universal Medica is seeking partners for its client, an international biopharmaceutical company and emerging leader in the field of oncology, to collaborate with to identify pre-clinical (with in vivo proof-of-concept) and early phase I research projects in the oncology therapeutics domain.

The client is primarily interested in highly innovative technologies, particularly biomarkers, small molecules, peptides, non-coding RNAs and antibodies, with novel first-in-class mechanisms of action.

Agencies and laboratories interested in learning more or with questions about this collaborative partnership opportunity should contact Dr. Shauna Katz at [email protected], or +33 (0) 1 41 12 27 77. 

Sign In or Register to comment.